FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

10841911000001108: Deferasirox 250mg dispersible tablets sugar free 28 tablet (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 02-Apr 2007. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
37257701000001115 Deferasirox 250mg dispersible tablets sugar free 28 tablet (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
37257801000001112 Deferasirox 250mg dispersible tablets sugar free 28 tablet en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

1 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Deferasirox 250mg dispersible tablets sugar free 28 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Deferasirox 250mg dispersible tablets sugar free 28 tablet Has NHS dm+d (dictionary of medicines and devices) freeness indicator Sugar free true Inferred relationship Existential restriction modifier
Deferasirox 250mg dispersible tablets sugar free 28 tablet Has dispensed dose form Dispersible tablet true Inferred relationship Existential restriction modifier
Deferasirox 250mg dispersible tablets sugar free 28 tablet Is a Virtual medicinal product pack true Inferred relationship Existential restriction modifier
Deferasirox 250mg dispersible tablets sugar free 28 tablet Is pack of Deferasirox 250mg dispersible tablets sugar free false Inferred relationship Existential restriction modifier
Deferasirox 250mg dispersible tablets sugar free 28 tablet Has active ingredient Deferasirox false Inferred relationship Existential restriction modifier
Deferasirox 250mg dispersible tablets sugar free 28 tablet Has manufactured dose form Dispersible tablet false Inferred relationship Existential restriction modifier
Deferasirox 250mg dispersible tablets sugar free 28 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Deferasirox 250mg dispersible tablets sugar free 28 tablet VMP non-availability indicator Available false Inferred relationship Existential restriction modifier
Deferasirox 250mg dispersible tablets sugar free 28 tablet Has VMP Deferasirox 250mg dispersible tablets sugar free true Inferred relationship Existential restriction modifier
Deferasirox 250mg dispersible tablets sugar free 28 tablet Has specific active ingredient Deferasirox true Inferred relationship Existential restriction modifier
Deferasirox 250mg dispersible tablets sugar free 28 tablet Has dispensed dose form Dispersible tablet false Inferred relationship Existential restriction modifier
Deferasirox 250mg dispersible tablets sugar free 28 tablet VMP non-availability indicator Not available true Inferred relationship Existential restriction modifier
Deferasirox 250mg dispersible tablets sugar free 28 tablet Has dispensed dose form Dispersible tablet false Inferred relationship Existential restriction modifier
Deferasirox 250mg dispersible tablets sugar free 28 tablet Has dispensed dose form Dispersible tablet false Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Exjade 250mg dispersible tablets (Novartis Pharmaceuticals UK Ltd) 28 tablet 4 x 7 tablets Is a True Deferasirox 250mg dispersible tablets sugar free 28 tablet Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start